ProShare Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

ProShare Advisors’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$605K	Sell	27,197 -4,481	-14%	-$107K	﹤0.01%	970
2025 Q4	$846K	Buy	31,678 +2,215	+8%	+$52.9K	﹤0.01%	875
2025 Q3	$629K	Sell	29,463 -4,553	-13%	-$108K	﹤0.01%	994
2025 Q2	$734K	Sell	34,016 -1,753	-5%	-$32.6K	﹤0.01%	929
2025 Q1	$594K	Sell	35,769 -5,811	-14%	-$106K	﹤0.01%	1001
2024 Q4	$763K	Buy	41,580 +9,164	+28%	+$148K	﹤0.01%	1034
2024 Q3	$499K	Buy	32,416 +5,790	+22%	+$96.6K	﹤0.01%	1138
2024 Q2	$433K	Sell	26,626 -6,957	-21%	-$112K	﹤0.01%	1053
2024 Q1	$621K	Buy	33,583 +3,048	+10%	+$75.5K	﹤0.01%	968
2023 Q4	$956K	Buy	30,535 +4,082	+15%	+$97.5K	﹤0.01%	765
2023 Q3	$551K	Buy	26,453 +169	+0.6%	+$4.59K	﹤0.01%	877
2023 Q2	$630K	Buy	26,284 +887	+3%	+$19.7K	﹤0.01%	855
2023 Q1	$478K	Sell	25,397 -3,465	-12%	-$66K	﹤0.01%	925
2022 Q4	$459K	Buy	28,862 +1,993	+7%	+$31.2K	﹤0.01%	1001
2022 Q3	$440K	Sell	26,869 -1,139	-4%	-$18.4K	﹤0.01%	951
2022 Q2	$395K	Sell	28,008 -13,722	-33%	-$256K	﹤0.01%	1049
2022 Q1	$1.01M	Sell	41,730 -10,009	-19%	-$242K	﹤0.01%	923
2021 Q4	$1.21M	Sell	51,739 -689	-1%	-$13.9K	﹤0.01%	936
2021 Q3	$871K	Sell	52,428 -11,630	-18%	-$224K	﹤0.01%	950
2021 Q2	$1.56M	Buy	64,058 +39,719	+163%	+$897K	﹤0.01%	811
2021 Q1	$628K	Sell	24,339 -2,279	-9%	-$100K	﹤0.01%	1294
2020 Q4	$1.42M	Sell	26,618 -783	-3%	-$38.9K	0.01%	741
2020 Q3	$1.13M	Buy	27,401 +668	+2%	+$28.8K	0.01%	692
2020 Q2	$1.3M	Sell	26,733 -3,095	-10%	-$149K	0.01%	642
2020 Q1	$1.26M	Sell	29,828 -21,426	-42%	-$883K	0.01%	555
2019 Q4	$2.19M	Sell	51,254 -2,329	-4%	-$101K	0.01%	605
2019 Q3	$1.93M	Sell	53,583 -3,218	-6%	-$97.6K	0.01%	600
2019 Q2	$1.52M	Sell	56,801 -8,894	-14%	-$227K	0.01%	645
2019 Q1	$1.76M	Buy	65,695 +4,195	+7%	+$98K	0.01%	625
2018 Q4	$994K	Sell	61,500 -4,960	-7%	-$96.3K	0.01%	704
2018 Q3	$1.38M	Sell	66,460 -1,313	-2%	-$20.7K	0.01%	693
2018 Q2	$1.03M	Buy	67,773 +7,596	+13%	+$135K	0.01%	815
2018 Q1	$1.35M	Sell	60,177 -9,386	-13%	-$260K	0.01%	719
2017 Q4	$2.1M	Sell	69,563 -1,682	-2%	-$53.8K	0.01%	593
2017 Q3	$2.68M	Buy	71,245 +6,600	+10%	+$215K	0.02%	502
2017 Q2	$1.8M	Sell	64,645 -2,165	-3%	-$64.5K	0.02%	586
2017 Q1	$2.3M	Sell	66,810 -14,556	-18%	-$514K	0.02%	522
2016 Q4	$2.35M	Buy	81,366 +2,678	+3%	+$70.8K	0.03%	502
2016 Q3	$2.5M	Sell	78,688 -8,511	-10%	-$289K	0.04%	428
2016 Q2	$2.83M	Sell	87,199 -8,397	-9%	-$281K	0.04%	372
2016 Q1	$2.67M	Sell	95,596 -144	-0.2%	-$3.14K	0.04%	369
2015 Q4	$3.41M	Buy	95,740 +8,409	+10%	+$296K	0.04%	363
2015 Q3	$2.89M	Sell	87,331 -2,866	-3%	-$119K	0.04%	378
2015 Q2	$3.78M	Sell	90,197 -5,733	-6%	-$222K	0.05%	339
2015 Q1	$3.13M	Buy	95,930 +12,962	+16%	+$446K	0.04%	423
2014 Q4	$2.63M	Buy	82,968 +466	+0.6%	+$13.2K	0.03%	492
2014 Q3	$2.04M	Sell	82,502 -15,947	-16%	-$373K	0.03%	708
2014 Q2	$2.22M	Sell	98,449 -42,427	-30%	-$886K	0.03%	672
2014 Q1	$3.43M	Buy	140,876 +95,783	+212%	+$2.42M	0.04%	420
2013 Q4	$1.13M	Sell	45,093 -30,368	-40%	-$716K	0.02%	948
2013 Q3	$2.07M	Buy	75,461 +58,622	+348%	+$1.23M	0.05%	383
2013 Q2	$306K	Buy	+16,839	New	+$232K	0.01%	1712